Role of erythrocytes and platelets in the hypercoagulable status in polycythemia vera through phosphatidylserine exposure and microparticle generation

Summary The development of thrombosis in polycythaemia vera (PV) involves multifactorial processes including pathological activation of blood cells. Release of microparticles (MPs) by activated cells in diseases is associated with thrombotic risk, but relatively few data are available in PV. The aim of the present study was to investigate the increase in MP release and exposure of phosphatidylserine (PS) on the outer membrane of MP-origin cells in patients with PV, and to analyse their procoagulant activity (PCA). PS-positive MPs and cells were detected by flow cytometry, while PCA was assessed with clotting time and purified coagulation complex assays. We found that PV patients had elevated circulating lactadherin+ MPs, which mostly originating from erythrocytes, platelets, granulocytes, and endothelial cells, as well as increased PS exposing erythrocytes/platelets as compared to secondary polycythaemia patients or healthy controls. These PS-bearing MPs and cells were highly procoagulant. Moreover, lactadherin competed factor V and VIII to PS and inhibited about 90% of the detected PCA in a dose-response manner while anti-TF antibody did no significant inhibition. Treatment with hydroxyurea is associated with a decrease in PS exposure and lactadherin+ MP release of erythrocytes/platelets. Our data demonstrate that PV patients are characterised by increased circulating procoagulant MPs and PS exposing erythrocytes/platelets, which could contribute to the hypercoagulable state in these patients.

[1]  G. Vilahur,et al.  Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques , 2012, Thrombosis and Haemostasis.

[2]  H. Büller,et al.  Coagulation activation and microparticle-associated coagulant activity in cancer patients , 2012, Thrombosis and Haemostasis.

[3]  M. Maier‐Redelsperger,et al.  The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles , 2012, Thrombosis and Haemostasis.

[4]  R. Landolfi,et al.  Thrombosis in myeloproliferative and myelodysplastic syndromes , 2012, Hematology.

[5]  V. Novakovic,et al.  Phagocytosis by macrophages and endothelial cells inhibits procoagulant and fibrinolytic activity of acute promyelocytic leukemia cells. , 2012, Blood.

[6]  C. Gao,et al.  Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome , 2012, Thrombosis and Haemostasis.

[7]  Ariel Roguin,et al.  Involvement of microparticles in diabetic vascular complications , 2011, Thrombosis and Haemostasis.

[8]  G. Lip,et al.  Circulating microparticles: new insights into the biochemical basis of microparticle release and activity , 2011, Basic Research in Cardiology.

[9]  G. E. Gilbert,et al.  Lactadherin functions as a probe for phosphatidylserine exposure and as an anticoagulant in the study of stored platelets , 2011, Vox sanguinis.

[10]  H. Fujita,et al.  Increased phosphatidylserine exposure on the erythrocyte membrane in patients with polycythaemia vera , 2011, British journal of haematology.

[11]  J. Freyssinet,et al.  Cellular Mechanisms Underlying the Formation of Circulating Microparticles , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[12]  R. Bertina,et al.  Pre-analytical and analytical issues in the analysis of blood microparticles , 2010, Thrombosis and Haemostasis.

[13]  M. Topbaş,et al.  Treatment related changes in antifibrinolytic activity in patients with polycythemia vera , 2010, Hematology.

[14]  R Lacroix,et al.  Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop , 2010, Journal of thrombosis and haemostasis : JTH.

[15]  Christian Weber,et al.  Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange , 2010, Circulation research.

[16]  Limin Li,et al.  Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release , 2010, Thrombosis and Haemostasis.

[17]  D. Rees,et al.  Role of Calcium in Phosphatidylserine Externalisation in Red Blood Cells from Sickle Cell Patients , 2010, Anemia.

[18]  V. Ugo,et al.  Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms. , 2010, Thrombosis research.

[19]  S. Grinstein,et al.  The distribution and function of phosphatidylserine in cellular membranes. , 2010, Annual review of biophysics.

[20]  B. Østerud.  Tissue factor expression in blood cells. , 2010, Thrombosis research.

[21]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[22]  José A López,et al.  Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: A mechanism associated with sickle cell disease , 2009, Thrombosis and Haemostasis.

[23]  J. Freyssinet,et al.  Centrifugation is a crucial step impacting microparticle measurement , 2009, Platelets.

[24]  P. Sonneveld,et al.  Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma , 2010, Thrombosis and Haemostasis.

[25]  Hongjuan Yu,et al.  Procoagulant activity and phosphatidylserine of amniotic fluid cells , 2008, Thrombosis and Haemostasis.

[26]  A. Falanga,et al.  Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia , 2008, Haematologica.

[27]  A. Falanga,et al.  Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation , 2008, Leukemia.

[28]  Tony Yeung,et al.  Membrane Phosphatidylserine Regulates Surface Charge and Protein Localization , 2008, Science.

[29]  T. Barbui,et al.  The haematocrit and platelet target in polycythemia vera , 2007, British journal of haematology.

[30]  C. W. Heegaard,et al.  Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[31]  Z. Berneman,et al.  The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. , 2006, Seminars in thrombosis and hemostasis.

[32]  C. W. Heegaard,et al.  Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature. , 2004, Biochimica et biophysica acta.

[33]  R. Hebbel,et al.  Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. , 2003, Blood.

[34]  G. E. Gilbert,et al.  Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites. , 2003, Blood.

[35]  J. Spivak,et al.  Polycythemia vera: myths, mechanisms, and management. , 2002, Blood.

[36]  M. Ellis,et al.  Phosphatidylserine Expression on the Platelet Membrane of Patients with Myeloproliferative Disorders and its Effect on Platelet-Dependent Thrombin Formation , 2002, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[37]  J. Rasmussen,et al.  Characterization of glycoprotein PAS-6/7 from membranes of bovine milk fat globules. , 1996, European journal of biochemistry.

[38]  A. Catania,et al.  Erythrocyte deformability evaluated by laser diffractometry in polycythemia vera. , 2012, Clinical hemorheology and microcirculation.

[39]  B. S. Baliga,et al.  Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium. , 2008, American journal of physiology. Heart and circulatory physiology.

[40]  T. Barbui,et al.  Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. , 2000, Blood.